StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
41
This month
1
This year
3
Publishing Date
2024 - 04 - 02
1
2024 - 03 - 07
1
2024 - 02 - 20
1
2023 - 12 - 15
1
2023 - 12 - 11
1
2023 - 11 - 27
1
2023 - 11 - 01
1
2023 - 10 - 03
1
2023 - 09 - 27
1
2023 - 09 - 07
1
2023 - 06 - 27
1
2023 - 06 - 06
1
2023 - 04 - 20
1
2023 - 04 - 18
1
2023 - 04 - 17
2
2023 - 04 - 06
1
2023 - 03 - 14
2
2023 - 01 - 31
1
2023 - 01 - 30
1
2023 - 01 - 24
1
2023 - 01 - 19
1
2023 - 01 - 12
1
2022 - 11 - 07
1
2022 - 11 - 01
1
2022 - 10 - 27
1
2022 - 09 - 23
1
2022 - 09 - 20
1
2022 - 08 - 10
1
2022 - 07 - 13
1
2022 - 07 - 06
1
2022 - 06 - 30
1
2022 - 05 - 09
1
2022 - 04 - 27
1
2022 - 02 - 15
1
2022 - 01 - 19
1
2021 - 12 - 01
1
2021 - 10 - 26
1
2021 - 10 - 11
1
2021 - 09 - 20
1
Sector
Communications
41
Health care and social assistance
2
Health technology
10
Professional, scientific, and technical services
1
Tags
Acquisition
75
America
56
Award
48
Awards
91
Business
73
California
164
Cancer
138
Care
44
Citrus
44
Conference
152
Corporation
54
Day
50
Designation
42
Energy
165
Europe
53
Expansion
52
Expected
43
Fda
63
Financial
182
Food
56
Global
217
Group
102
Growth
185
Health
163
Home
71
International
44
Life
44
Management
50
Market
1012
Medical
66
Meeting
97
Mobile
60
N/a
6832
Network
52
One
46
Order
45
Partnership
83
Patent
84
Platform
43
Program
80
Reach
575
Report
251
Research
729
Results
330
Sales
69
Service
66
Services
136
Smart
53
Solar
48
Solutions
50
Study
43
System
71
Technology
86
Therapeutics
66
Treatment
84
Trial
66
Update
64
Water
81
Work
47
Year
158
Entities
Abbvie inc.
1
Acumen pharmaceuticals inc
1
Alignment healthcare inc
4
Atyr pharma, inc.
1
Axonics modulation technologies, inc.
1
Biocorrx inc.
2
Evofem biosciences, inc.
2
Evoke pharma, inc.
1
Fortress biotech, inc.
1
Masimo corporation
1
Mustang bio, inc.
1
Novabay pharmaceuticals, inc.
1
Orange
41
Regulus therapeutics inc.
1
Symbols
AADI
18
ACAD
44
AMGN
13
ARCT
24
ARWR
30
AXIM
13
AXNX
19
BIOC
24
CDXC
19
CRDF
13
CRNX
13
DARE
27
DXCM
14
ENSC
15
EOLS
17
EQ
19
ERAS
13
ESTA
18
EVFM
28
EVOK
13
FLGT
21
FNCTF
41
GKOS
24
GOSS
14
HRTX
13
ILMN
19
IMMX
14
INBX
13
INGN
19
IONS
14
JNJ
46
KTRA
24
LBPH
13
LCTX
26
LGND
29
LIFE
28
LLY
17
MASI
25
MS
23
NBIX
26
NUVA
15
PALI
16
PBYI
21
PHAS
17
PSTX
22
QDEL
24
QLGN
13
REVB
13
RGLS
17
RNA
22
SLP
36
SNY
24
SNYNF
14
SRNE
19
TAK
17
TMO
25
VIRX
15
VKTX
17
XNCR
23
ZNTL
14
Exchanges
Amex
1
Nasdaq
41
Nyse
1
Crawled Date
2024 - 04 - 02
1
2024 - 03 - 07
1
2024 - 02 - 20
1
2023 - 12 - 15
1
2023 - 12 - 11
1
2023 - 11 - 27
1
2023 - 11 - 01
1
2023 - 10 - 03
1
2023 - 09 - 27
1
2023 - 09 - 07
1
2023 - 06 - 27
1
2023 - 06 - 06
1
2023 - 04 - 20
1
2023 - 04 - 18
1
2023 - 04 - 17
2
2023 - 04 - 06
1
2023 - 03 - 15
2
2023 - 01 - 31
1
2023 - 01 - 30
1
2023 - 01 - 24
1
2023 - 01 - 19
1
2023 - 01 - 12
1
2022 - 11 - 07
1
2022 - 11 - 01
1
2022 - 10 - 27
1
2022 - 09 - 23
1
2022 - 09 - 20
1
2022 - 08 - 10
1
2022 - 07 - 13
1
2022 - 07 - 06
1
2022 - 06 - 30
1
2022 - 05 - 09
1
2022 - 04 - 27
1
2022 - 02 - 15
1
2022 - 01 - 19
1
2021 - 12 - 01
1
2021 - 10 - 26
1
2021 - 10 - 11
1
2021 - 09 - 20
1
Crawled Time
00:00
2
12:00
2
12:30
1
13:00
2
13:20
1
14:00
5
14:20
2
14:30
3
15:30
1
16:00
4
17:00
4
18:00
2
19:00
4
20:00
2
21:00
3
22:00
2
23:00
1
Source
www.biospace.com
41
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Biotech-beach
symbols :
FNCTF
save search
Biological Dynamics Announces Expanding Adoption of ExoVerita™ Pro Under Early Access Program
Published:
2024-04-02
(Crawled : 14:30)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-1.91%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
pro
program
City of Hope-developed Chimeric Antigen Receptor (CAR) T Cell Therapy Shows Clinical Activity in Patients With Aggressive Brain Tumors in a Phase 1 Trial
Published:
2024-03-07
(Crawled : 12:30)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-3.03%
|
O:
0.79%
H:
0.78%
C:
0.78%
MBIO
|
$0.373
7.74%
7.18%
440K
|
Health Technology
|
-71.21%
|
O:
8.33%
H:
4.2%
C:
-2.8%
FBIO
|
$1.79
1.7%
1.68%
240K
|
Health Technology
|
-20.54%
|
O:
2.93%
H:
0.0%
C:
-9.21%
tumors
cell
city
trial
therapy
Harvard Eye Associates Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma
Published:
2024-02-20
(Crawled : 20:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
glaucoma
ocular
offering
treatment
hypertension
eye
Astiva Health Files Statement for Proposed Initial Public Offering
Published:
2023-12-15
(Crawled : 21:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
health
offering
City of Hope Scientists Present Promising New Research at American Society of Hematology Annual Meeting
Published:
2023-12-11
(Crawled : 20:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
hope
city
research
meeting
NEURELIS SECURES NEW ORANGE BOOK LISTED U.S. PATENT FOR VALTOCO® (DIAZEPAM NASAL SPRAY) CIV
Published:
2023-11-27
(Crawled : 19:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
valtoco
patent
Vibrato Medical Announces Positive Results for Early Feasibility Study of Wearable, Non-Invasive Therapeutic Ultrasound to Treat Chronic Limb-Threatening Ischemia (CLTI)
Published:
2023-11-01
(Crawled : 21:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-9.17%
|
O:
-1.44%
H:
0.0%
C:
-1.88%
positive
treat
medical
results
study
City of Hope Opens First U.S. Multicenter Clinical Trial for Robotic Single-Port Mastectomies for Breast Cancer Patients
Published:
2023-10-03
(Crawled : 16:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
breast
hope
cancer
city
trial
Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire
Published:
2023-09-27
(Crawled : 14:30)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-5.19%
|
O:
-2.28%
H:
0.0%
C:
0.0%
phexxi
fda
approval
market
New Multicenter Study Reveals Neurological Pupil index™ (NPi) as Predictor of Outcome and Mortality in Brain Injury Patients
Published:
2023-09-07
(Crawled : 17:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
0.6%
|
O:
5.1%
H:
0.0%
C:
0.0%
predictor
neurological
study
City of Hope diabetes experts present new research on beta cells, insulin secretion and islet transplantation at annual American Diabetes Association (ADA) Conference
Published:
2023-06-27
(Crawled : 14:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
conference
association
hope
city
research
diabetes
insulin
New study finds continuing immunotherapy once cancer progresses doesn't work and could cause harm
Published:
2023-06-06
(Crawled : 19:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
work
cancer
immunotherapy
study
United States Patent and Trademark Office (USPTO) Grants Evoke Pharma a Formulation Patent Covering GIMOTIThe Company Will Submit for FDA Orange-Book Listing in the Near Term
Published:
2023-04-20
(Crawled : 14:20)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-13.65%
|
O:
-0.47%
H:
0.0%
C:
0.0%
EVOK
|
News
|
$0.549
16.81%
14.39%
19K
|
Health Technology
|
-77.62%
|
O:
15.24%
H:
0.0%
C:
-11.57%
fda
pharma
patent
grants
Primmune Therapeutics Presents New Clinical Data from Phase 1 Study Evaluating PRTX007 in Healthy Volunteers at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Published:
2023-04-18
(Crawled : 14:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
prtx007
association
cancer
research
meeting
therapeutics
study
City of Hope scientists present potential new treatments for chronic lymphocytic leukemia, myelofibrosis and other diseases at American Association of Cancer Research (AACR) Annual Meeting
Published:
2023-04-17
(Crawled : 16:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
association
hope
cancer
city
research
meeting
potential
aTyr Pharma Presents Preclinical Research Demonstrating Treatment with ATYR2810 Inhibits Tumor Growth and Therapy Resistance in Highly Aggressive Cancers at the 2023 AACR Annual Meeting
Published:
2023-04-17
(Crawled : 14:00)
- biospace.com/
LIFE
|
$1.59
-1.24%
-1.26%
540K
|
Health Technology
|
-16.75%
|
O:
1.05%
H:
1.04%
C:
-0.52%
atyr2810
pharma
treatment
tumor
research
preclinical
meeting
therapy
growth
City of Hope appoints John D. Carpten, Ph.D., as director of its comprehensive cancer center and Beckman Research Institute, and chief scientific officer
Published:
2023-04-06
(Crawled : 19:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-10.61%
|
O:
-0.36%
H:
0.0%
C:
0.0%
hope
cancer
city
research
Primmune Therapeutics to Present New Clinical Data from Phase 1 Study Evaluating PRTX007 at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Published:
2023-03-14
(Crawled : 00:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
prtx007
research
meeting
association
therapeutics
cancer
study
phase 1
Onchilles Pharma Announces Presentation of Preclinical Data for N17350 at AACR 2023
Published:
2023-03-14
(Crawled : 00:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
pharma
preclinical
presentation
Alignment Healthcare to Announce Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call Tuesday, Feb. 28, 2023
Published:
2023-01-31
(Crawled : 16:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
7.14%
|
O:
0.68%
H:
0.0%
C:
0.0%
ALHC
|
$4.945
0.92%
0.91%
780K
|
|
-58.72%
|
O:
0.17%
H:
4.54%
C:
3.87%
conference
financial
results
← Previous
1
2
3
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.